The enhanced permeability and retention (EPR) effect, resulting from the leaky tumor vasculature, combined with the overexpression of low-density lipoprotein receptors, enables the passive delivery of the PS to tumor sites [17]. The gene discussed is LDLR; the disease is neoplasm.